Diagnostic markers for rare neuro-immune disorders
May 25, 2018, EDT @ 1:00 pm, EDT - 2:00 pm, EDT
SEND US YOUR QUESTIONS FOR THE EXPERTS HERE
(During the podcast, you can interact with the moderator through our TMA Facebook page, or using the chat function in GoToWebinar)
Michael Levy, MD, PhD
Dr. Michael Levy is an Associate Professor of Neurology and the Medical Director of General Neurology at the Johns Hopkins Hospital in Baltimore, MD. Dr. Levy specializes in taking care of patients with neuroimmunologic diseases including multiple sclerosis, transverse myelitis, optic neuritis and neuromyelitis optica. In the laboratory, Dr. Levy’s research focus is on the development of neural stems for regenerative therapy in these diseases. He uses rat and mouse models to test the survival, differentiation and functional capacity of human neural stem cells to improve neurologic function in post-inflammatory conditions. The goal of his laboratory and clinical effort is to translate the basic science stem cell work to a human trial in transverse myelitis and other neuroimmunologic diseases.
Carlos Pardo-Villamizar, MD
Dr. Pardo is an Associate Professor of Neurology (Division of Neuroimmunology and Neuroinfectious Disorders) and Pathology (Neuropathology) at Johns Hopkins University School of Medicine in Baltimore, Maryland. He is the principal investigator of the Neuroimmunopathology Laboratory, member of the HIV Neurosciences Research Group and clinical neurologist at the Multiple Sclerosis and Transverse Myelitis Centers at Johns Hopkins Hospital. His clinical specialization is on neuroimmunological and Infectious disorders of the nervous system, with particular focus on multiple sclerosis, transverse myelitis, neurosarcoidosis, and neurological complications of autoimmune disorders.
Listen to previous Ask the Expert podcasts here